CD8A and neoplasm: Taken together, our findings indicate that treatment with KRASG12Ci results in increased expression of the intrinsic mechanism of resistance pan-HERs and immune escape mechanisms including PD-L1 by tumor cells, and concomitant accumulation of CAFs that presumably suppress the activity of the infiltrated CD8+ T cells.